HYQVIA
NDC 0944-2514, Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase, kit, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 0944-2514
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125402
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0944-2514-02 | 00944251402 | 1 KIT in 1 CARTON (0944-2514-02) * 300 mL in 1 VIAL, GLASS (0944-2719-30) * 15 mL in 1 VIAL, GLASS (0944-2724-03) |
Linked data
RxNorm, label and prices
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0944-2514
Use it
Look up 0944-2514 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0944-2514. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.